{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"oligodendroglioma-idh-mutant-and-1p-19q-codeleted-grade-2","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as a well differentiated tumor lacking anaplastic features (brisk mitotic activity, microvascular proliferation, necrosis).","mondoId":"MONDO:0956996","node":{"canonicalSlug":"oligodendroglioma-idh-mutant-and-1p-19q-codeleted-grade-2","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2","paragraphs":["An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as a well differentiated tumor lacking anaplastic features (brisk mitotic activity, microvascular proliferation, necrosis)."],"scope":"exact","source":"MONDO","upstream":"DOID:0081281","url":"https://monarchinitiative.org/MONDO:0956996"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"IDH-mutant and 1p/19q-codeleted oligodendroglioma","mondoId":"MONDO:0859592","slug":"idh-mutant-and-1p-19q-codeleted-oligodendroglioma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26783"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0956996\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0081281</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An IDH-mutant, and 1p/19q-codeleted oligodendroglioma that is characterized as a well differentiated tumor lacking anaplastic features (brisk mitotic activity, microvascular proliferation, necrosis).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0956996\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"oligodendroglioma-idh-mutant-and-1p-19q-codeleted-grade-2","sourceDocuments":[{"name":"MONDO: oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0956996"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"oligodendroglioma, IDH-mutant and 1p/19q-codeleted grade 2"},"schemaVersion":1}
